Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: j bayer who wrote (6939)	4/13/1998 10:01:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

Good News for Vivus! Zacks increases Q2 estimates to .14 and FY '98 to .80. Also an upgrade from buy to strong buy. At todays closing price Vivus has a forward PE of 11. A reasonable PE of 20 would give us a price of 16. An average drug stock PE of 30 would give us a price of 24. I predict a buy out (Maybe Johnson and Johnson?) if Vivus stays at these levels for a prolonged span of time.

To: j bayer who wrote (6939)	4/13/1998 10:06:00 PM
From: Zebra 365	Read Replies (1) \| Respond to of 23519

I think you can believe everything that EyeDrMike said but that last line. Nina did not say anything about the future price of the stock, he was kidding. BTW I have to clear up something that is my fault, in the billboard at the top of the thread, I said the Ireland plant was planned to be operational in 1999, that is wrong, it will be operational in 2000. However, once the new plant (in New Jersey) is fully approved, there will not be capacity constraints like the first year and a half of the company history. They should be able to do up to 5-7 million units per quarter with lower overall costs per unit. In a humorous note, Dr. "let's ride a bike" Irwin Goldstein has decided that, since vaginal tissue blood flow increases when women are sexually stimulated, using Viagra to enhance sexual response in women by increasing vaginal tissue blood flow is a Good Idea. In a related story Dr. Goldstein has donated all of his Pfizer grants for the next 12 months to the "Wag the Dog Society", a not-for-profit organization that trains volunteers to go out into the community and make dogs happy by moving their tails back and forth. Zebra